Page 2380 - Williams Hematology ( PDFDrive )
P. 2380

2350  Part XIII:  Transfusion Medicine                   Chapter 136: Erythrocyte Antigens and Antibodies            2351




                    42.  Cartron JP: Molecular basis of red cell protein antigen deficiencies. Vox Sang 78:7, 2000.    52.  Rock JA, Shirey RS, Braine HG, et al: Plasmapheresis for the treatment of repeated early
                    43.  Lee S, Russo D, Redman CM: The Kell blood group system: Kell and XK membrane   pregnancy wastage associated with anti-P. Obstet Gynecol 66:57S, 1985.
                     proteins. Semin Hematol 37:113, 2000.                53.  Udden MM, Umeda M, Hirano Y, Marcus DM: New abnormalities in the morphology,
                    44.  Danek A, Rubio JP, Rampoldi L, et al: McLeod neuroacanthocytosis: Genotype and   cell surface receptors, and electrolyte metabolism of In(Lu) erythrocytes. Blood 69:52,
                     phenotype. Ann Neurol 50:755, 2001.                   1987.
                    45.  Luhn K, Wild MK, Eckhardt M, et al: The gene defective in leukocyte adhesion      54.  Heaton DC, McLoughlin K: Jk(a–b–) red blood cells resist urea lysis. Transfusion 22:70,
                     deficiency II encodes a putative GDP-fucose transporter. Nat Genet 28:69, 2001.  1982.
                    46.  Etzioni A, Tonetti M: Leukocyte adhesion deficiency II-from A to almost Z. Immunol     55.  Sands JM: Molecular mechanisms of urea transport. J Membr Biol 191:149, 2003.
                     Rev 178:138, 2000.                                   56.  Standards Committee of American Association of Blood Banks: Standards for Blood
                    47.  Yu L-C, Twu Y-C, Chang C-Y, Lin M: Molecular basis of the adult i phenotype and the   Banks and Transfusion Services, 29th ed. American Associations of Blood Banks,
                     gene responsible for the expression of the human blood group I antigen. Blood 98:3840,   Bethesda, MD, 2014.
                     2001.                                                57.  Springer GF, Horton RE, Forbes M: Origin of anti-human blood group B agglutinins in
                    48.  Inaba N, Hiruma T, Togayachi A, et al: A novel I-branching beta-1,6-N-acetylglu-  white leghorn chicks. J Exp Med 110:221, 1959.
                     cosaminyltransferase involved in human blood group I antigen expression.  Blood     58.  Springer GF, Horton RE: Blood group isoantibody stimulation in man by feeding blood
                     101:2870, 2003.                                       group-active bacteria. J Clin Invest 48:1280, 1969.
                    49.  Yu LC, Twu YC, Chou ML, et al: The molecular genetics of the human I locus and     59.  Reid ME, Øyen R, Marsh WL: Summary of the clinical significance of blood group
                     molecular background explaining the partial association of the adult i phenotype with   alloantibodies. Semin Hematol 37:197, 2000.
                     congenital cataracts. Blood 101:2081, 2003.          60.  Poole J, Daniels G: Blood group antibodies and their significance in transfusion medi-
                    50.  Agre P, King LS, Yasui M, et al: Aquaporin water channels—From atomic structure to   cine. Transfus Med Rev 21:58, 2007.
                     clinical medicine. J Physiol 542:3, 2002.
                    51.  Crew VK, Burton N, Kagan A, et al: CD151, the first member of the tetraspanin (TM4)
                     superfamily detected on erythrocytes, is essential for the correct assembly of human
                     basement membranes in kidney and skin. Blood 104:2217, 2004.



































































          Kaushansky_chapter 136_p2327-2352.indd   2351                                                                 9/21/15   4:32 PM
   2375   2376   2377   2378   2379   2380   2381   2382   2383   2384   2385